These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 11076479)

  • 1. [Choice of drugs--by whom, for whom and to what costs?].
    Frisk M; Strömstedt A
    Lakartidningen; 2000 Sep; 97(39):4343-6. PubMed ID: 11076479
    [No Abstract]   [Full Text] [Related]  

  • 2. [Drug committees should be abolished because the reality has changed].
    Jönsson B; Arvidsson G; Levin LA; Rehnberg C
    Lakartidningen; 2005 Mar 14-20; 102(11):880-1; discussion 882-3. PubMed ID: 15835525
    [No Abstract]   [Full Text] [Related]  

  • 3. [Reply 1: LAKSAK supports wise drug therapy using knowledge and sharp IT-tools].
    Gustafsson LL; Hensjö LO
    Lakartidningen; 2000 Sep; 97(39):4347. PubMed ID: 11076480
    [No Abstract]   [Full Text] [Related]  

  • 4. [Feedback on prescribing profiles at a primary health center. Important element in quality assurance of drug prescription].
    Nyman K; Bergens A; Björin AS; Guterstam P; Nyrén O; Jansson U; Wettermark B; Bergman U
    Lakartidningen; 2001 Jan; 98(3):160-4. PubMed ID: 11271576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of the non-hospitalised patient and the consumption of drugs].
    Bergfors PG; Hallgren CG; O'gren JE
    Lakartidningen; 1980 Mar; 77(11):1002-4. PubMed ID: 7374251
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug committees in Denmark. Status and future challenges].
    Rabøl R; Kampmann JP; Christensen HR
    Ugeskr Laeger; 2004 Aug; 166(35):2988-91. PubMed ID: 15387009
    [No Abstract]   [Full Text] [Related]  

  • 7. [Medical experts groups and choice of medications. A fair prioritization process guarantees the reliability of the choice of medications].
    Garpenby P
    Lakartidningen; 2004 Aug; 101(32-33):2480-2, 2484. PubMed ID: 15346621
    [No Abstract]   [Full Text] [Related]  

  • 8. [Health economics evaluations are of great significance for Pharmaceutical Benefit Board's decisions].
    Persson U; Ramsberg J
    Lakartidningen; 2007 Oct 17-23; 104(42):3046-50. PubMed ID: 17985712
    [No Abstract]   [Full Text] [Related]  

  • 9. [The discussion on the choice of drugs requires more facts].
    Widäng K
    Lakartidningen; 1999 Sep; 96(38):4011. PubMed ID: 10526457
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cost savings by right choice of drugs. Decision making models for "good prescription" are presented].
    Hoffmann M
    Lakartidningen; 1997 Feb; 94(9):733-6, 739. PubMed ID: 9091750
    [No Abstract]   [Full Text] [Related]  

  • 11. [Open discussion on the choice of drugs is better than centralized supervision].
    Waller G
    Lakartidningen; 1999 Aug; 96(32-33):3404. PubMed ID: 10479792
    [No Abstract]   [Full Text] [Related]  

  • 12. Rational drug use. Part I: The role of national drug policies.
    Manyemba J; Dzuda C; Nyazema NZ
    Cent Afr J Med; 2000 Aug; 46(8):229-32. PubMed ID: 11317597
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lists presented by eight drug committees compared. The number of preparations varies. Similar views on the most expensive drugs].
    Bergman U; Myrhed M
    Lakartidningen; 1996 Apr; 93(15):1459-60. PubMed ID: 8667738
    [No Abstract]   [Full Text] [Related]  

  • 14. [Realities and paradoxes].
    Morel A
    Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():1S4. PubMed ID: 11435988
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug information--national decision needed].
    Ohman U; Nilsson A
    Lakartidningen; 2008 Jul 9-22; 105(28-29):2038. PubMed ID: 18711826
    [No Abstract]   [Full Text] [Related]  

  • 16. [The DU90% is a new quality measure for drug prescription. Non-steroidal anti-inflammatory agents as an example for analysis].
    Bergman U; Wettermark B; Myrhed M; Arrhenius L
    Lakartidningen; 1998 Sep; 95(39):4237-8, 4241-2. PubMed ID: 9785772
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug utilization studies and epidemiology.
    Tognoni G; Liberati A; Pellò L; Sasanelli F; Spagnoli A
    Rev Epidemiol Sante Publique; 1983; 31(1):59-71. PubMed ID: 6856922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Health economic evaluation of recommended drug treatment].
    Jendteg S; Persson U; Anell A
    Lakartidningen; 2002 Jul; 99(30-31):3130-1. PubMed ID: 12198934
    [No Abstract]   [Full Text] [Related]  

  • 19. There is a trend in the utilization of psychotropics among elderly towards recommended drugs.
    Lesén E; Carlsten A
    Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):1095-9. PubMed ID: 20712025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug committees are not necessary--therapeutic recommendations are issued anyway].
    Jönsson B
    Lakartidningen; 2005 Jul 11-24; 102(28-29):2085-6: discussion 290-2. PubMed ID: 16097181
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.